Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AQ-101 |
Trade Name | |
Synonyms | AQ101|AQ 101 |
Drug Descriptions |
AQ-101 interferes with the interaction between MDM2 and MDM4 and induces degradation of MDM2, resulting in activation of Tp53, and potentially leading to decreased proliferation and increased apoptosis of tumor cells (PMID: 29282301). |
DrugClasses | MDM2 Inhibitor 23 |
CAS Registry Number | 1353384-61-8 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AQ-101 | AQ-101 | 1 | 0 |